In view of the COVID-19 situation and the local measures to further contain the spread, GMS5103 Regulation of Cell, Tissue and Gene Therapies (22-26 June 2020) will be conducted remotely:

The workshop programmes has been re-arranged to accommodate the logistics involved. Students will require a laptop or computer with a video camera and internet access for the duration of the workshop.

We seek your kind understanding on the necessary changes to deliver the same quality of our programmes to you, and your continued support to CoRE and measures to counter COVID19. Should you have any queries, kindly contact us at CoRE_Education@duke-nus.edu.sg

Advanced therapies, covering the scope of cellular, tissue and gene treatment modalities, is a rapidly advancing field that offers exciting new therapeutic possibilities and constantly challenges the regulatory environment to expedite access to these innovations. Through this module, an understanding is gained on the various frameworks and practices regulating advanced therapies, including requirements for product evaluation and dossier submission for an effective product life cycle management. The module will interest students who are keen in global trending regulatory approaches and strengthening the skill sets to accommodate new innovation. There is also a focus on promoting convergence of regulatory approaches for advanced therapies.